Myeloma protein
Myeloma Protein
Myeloma protein (pronounced: my-uh-LOH-muh PROH-teen) is a type of protein produced by plasma cells in the bone marrow. It is associated with multiple myeloma, a type of cancer that affects plasma cells.
Etymology
The term "myeloma" is derived from the Greek words "myelos" (meaning marrow) and "oma" (meaning tumor). The term "protein" comes from the Greek word "proteios", meaning "primary" or "in the lead".
Description
Myeloma proteins are abnormal proteins that are produced in excess by malignant plasma cells. These proteins can be detected in the blood and urine of individuals with multiple myeloma. The presence of myeloma proteins can interfere with the normal functioning of the kidneys and can lead to kidney damage or kidney failure.
Related Terms
- Monoclonal protein: Another term for myeloma protein. It refers to the fact that the protein is produced by a single clone of plasma cells.
- Bence Jones protein: A specific type of myeloma protein that is found in the urine. It is named after the British physician Henry Bence Jones, who first discovered it.
- Paraprotein: A general term for abnormal proteins produced by plasma cells. Myeloma protein is a type of paraprotein.
See Also
External links
- Medical encyclopedia article on Myeloma protein
- Wikipedia's article - Myeloma protein
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski